One study finds a significant increase in C auris bloodstream infections in US hospitals.
Several Arizona marijuana establishments have voluntarily recalled certain products over potential contamination with Aspergillus and Salmonella.
The increase was driven by COVID-19–associated fungal infections.
FDA scientists say that a monovalent XBB lineage COVID vaccine is warranted for a fall vaccine campaign.
Rise of the multidrug-resistant fungal pathogen was driven primarily by COVID-19 surges and mechanical ventilation, the authors say.
CDC researchers review 192 C auris–associated hospitalizations, including 38 C auris bloodstream infections (20%), and note a crude mortality rate of 34%.
Fourteen suspected and 11 probable US meningitis cases have been reported in an outbreak tied to cosmetic surgery in clinics in Matamoros, Mexico.
Mexican health officials have identified Fusarium solani, a common soil fungus, in cerebrospinal fluid samples from five American women.
The number of suspected or probable fungal meningitis infections tied to contaminated spinal anesthesia products from Mexico has risen to 18 in the US.
Two unrelated cases suggest that a severe, antifungal-resistant tinea is now being locally transmitted in the US.
